• About us
• Contact

Advertisement

Person › Details

Jean Stéphenne (GlaxoSmithKline Biologicals S.A. (GSK Biologicals))

Stéphenne, Jean (GSK Biologicals 200512 President)

 

	Organisation	GlaxoSmithKline Biologicals S.A. (GSK Biologicals)
	Group	GSK (Group)
	Product	vaccine

Record changed: 2023-07-23

Advertisement

More documents for Jean Stéphenne

• [1] CureVac N.V.. (7/14/23). "Press Release: CureVac Announces Update to the Management Team". Tübingen & Boston, MA....
• [2] CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London....
• [3] Bone Therapeutics S.A.. (4/26/18). "Press Release: Bone Therapeutics Strengthens Board with the Appointment of Claudia D’Augusta as Non-Executive Director". Gosselies....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.